EMD-27765

Single-particle
3.27 Å
EMD-27765
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27765

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8dwx summary report (pdf.gz) Map-8dwx FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit)

EMD-27765

Single-particle
3.27 Å
EMD-27765
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Chikungunya virus strain Senegal 37997, Homo sapiens
Sample: Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit)
Fitted models: 8dwx

Deposition Authors: Adams LJ , Fremont DH
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.
Raju S , Adams LJ , Earnest JT , Warfield K , Vang L , Crowe Jr JE , Fremont DH , Diamond MS
(2023) Sci Transl Med , 15 , eade8273 - eade8273
PUBMED: 37196061
DOI: doi:10.1126/scitranslmed.ade8273
ISSN: 1946-6242